A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT04021862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT04021862
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2019
- Primary completion
- Jun 29, 2020
- Completion
- Nov 18, 2020
- Last update posted
- Feb 3, 2025
2019 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Beach Clinical Research Inc | Huntington Beach | California | 92647 | — |
| Florida Academic Dermatology Centers | Coral Gables | Florida | 33134 | — |
| Doral Medical Research | Doral | Florida | 33166 | — |
| Floridian Research Institute | Miami | Florida | 33145 | — |
| Florida International Medical Research | Miami | Florida | 33155 | — |
| Premier Research Associate, Inc | Miami | Florida | 33165 | — |
| CNS HealthCare | Orlando | Florida | 32801 | — |
| Avita Clinical Research | Tampa | Florida | 33613 | — |
| Forcare Clinical Research Inc | Tampa | Florida | 33613 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46256 | — |
| Randall Dermatology & Cosmetic Surgery | West Lafayette | Indiana | 47906 | — |
| Revival Research Institute LLC | Troy | Michigan | 48084 | — |
| ClinOhio Research Services | Columbus | Ohio | 43213 | — |
| Helios Clinical Research, LLC | Milan | Tennessee | 38358 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Dominion Medical Associates, Inc. | Richmond | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04021862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2025 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04021862 live on ClinicalTrials.gov.